Cognition Therapeutics (NASDAQ:CGTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Cognition Therapeutics (CGTX) operate in?

Cognition Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Cognition Therapeutics Stock (NASDAQ: CGTX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	1.10K / 7.53M
Day Range	- - -
52 Wk Range	0.34 - 2.95
Market Cap	$27.01M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	2.14%
Days to Cover	1

Recent News

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Oct 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	1.10K / 7.53M
Day Range	- - -
52 Wk Range	0.34 - 2.95
Market Cap	$27.01M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	2.14%
Days to Cover	1

About Cognition Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery an...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cognition Therapeutics (CGTX) stock?

You can purchase shares of Cognition Therapeutics (NASDAQ:CGTX) through any online brokerage.

View our list of the best stock brokerages

Who are Cognition Therapeutics (CGTX) competitors?

Other companies in Cognition Therapeutics’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP) and CalciMedica (NASDAQ:CALC).

What is the forecast, or price target, for Cognition Therapeutics (CGTX) stock?

Cognition Therapeutics has a consensus price target of $7.92.

What is the current price for Cognition Therapeutics (CGTX)?

The stock price for Cognition Therapeutics (NASDAQ: CGTX) is $0.65 last updated February 10, 2025 at 4:57 AM EST.

Does Cognition Therapeutics (CGTX) pay a dividend?

There are no upcoming dividends for Cognition Therapeutics.

When is Cognition Therapeutics (NASDAQ:CGTX) reporting earnings?

Cognition Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is Cognition Therapeutics (CGTX) going to split?

There is no upcoming split for Cognition Therapeutics.

What sector and industry does Cognition Therapeutics (CGTX) operate in?

Cognition Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Cognition Therapeutics

Cognition Therapeutics (CGTX) Forecast